Series Ventures

Type

Venture Capital

Location

Changwon, South Korea

Total investments

37

Average round size

723K

Portfolio companies

32

Rounds per year

5.29

Lead investments

19

Follow on index

0.14

Exits

1

Areas of investment
AutomotiveBiotechnologyE-CommerceInformation TechnologyArtificial IntelligenceFood and BeverageHealth CareManufacturingMedicalPharmaceutical

Investor highlights

Industry focus
Climate techHealthcareB2B/EnterpriseFashionCommunity/Social network Show 1 more
Geo focus

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
37
Lead investments
19
Exits
1
Rounds per year
5.29
Follow on index
0.14
Investments by industry
  • Food and Beverage (7)
  • E-Commerce (6)
  • Manufacturing (6)
  • Biotechnology (5)
  • Medical (5)
  • Show 48 more
Investments by region
  • South Korea (37)
Peak activity year
2021

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
3
Avg. valuation at time of investment
568K
Group Appearance index
0.54

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Cryotech 11 Jun 2024 Seed Kyonggi-do, Seongnam, South Korea
Simply Care Bio 31 Jul 2023 Biotechnology, Food and Beverage, Wellness Seed 1M Seoul, Seoul-t'ukpyolsi, South Korea
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.